Status:
COMPLETED
Trial of IV NTG for CD After Second Stage Arrest for the Prevention of Uterine Extension
Lead Sponsor:
University of California, San Francisco
Conditions:
Prolonged Second Stage of Labor
Eligibility:
FEMALE
18-60 years
Phase:
PHASE4
Brief Summary
Randomized controlled clinical trial of IV nitroglycerin at cesarean delivery for second stage arrest of descent to prevent or uterine extension at the hysterectomy site.
Detailed Description
Intravenous nitroglycerin resulting in uterine relaxation has been standardly utilized for various obstetrics conditions, e.g. breech extraction of second twin in vaginal deliveries, uterine relaxatio...
Eligibility Criteria
Inclusion
- women 37weeks or greater gestation diagnosed with second stage arrest of descent undergoing cesarean delivery -
Exclusion
- elective, active phase arrest cesarean delivery, successful operative vaginal delivery
- \-
Key Trial Info
Start Date :
October 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02265965
Start Date
October 1 2015
End Date
July 1 2018
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University California San Francisco-Labor and Delivery
San Francisco, California, United States, 94143